Urine drug test interpretation: What do physicians know?

Journal of Opioid Management

Volumn 3, Issue 2, 2007, Pages 80-85

  Reisfield, Gary M ^a   Bertholf, Roger ^a   Barkin, Robert L ^b   Webb, Fern ^a   Wilson, George ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b University Medical Center   (United States)

Author keywords

Chronic opioid therapy; Interpretation; Physician knowledge; Urine drug test

Indexed keywords

CANNABIS; CODEINE; DIAMORPHINE; HYDROMORPHONE; MORPHINE; OPIATE;

ARTICLE; BIVARIATE ANALYSIS; CLINICAL ASSESSMENT TOOL; CLINICAL COMPETENCE; DRUG URINE LEVEL; HUMAN; LABORATORY PERSONNEL; LONG TERM CARE; MEDICAL EDUCATION; MEDICAL PRACTICE; PATIENT MONITORING; PHYSICIAN; PROFESSIONAL KNOWLEDGE; QUESTIONNAIRE;

EID: 34248597548     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2007.0044     Document Type: Article

References (15)

1. Dasgupta N, Kramer ED, Zalman MA: Association between non-medical and prescriptive usage of opioids. Drug Alcohol Depend. 2006; 82(2): 135-142.
2. Gilson AM, Ryan KM, Joranson DE, et al.: A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002. J Pain Symptom Manage. 2004; 28(2): 176-188.
3. Chelminksi PR, Ives TJ, Felix KM, et al.: A primary care, multidisciplinary disease management program for opioid-treated patients with chronic non-cancer pain and a high burden of psychiatric comorbidity. BMC Health Serv Res. 2005; 5(1): 3.
4. Rounsaville BJ, Petry NM, Carroll KM: Single versus multiple drug focus in substance abuse clinical trials research. Drug Alcohol Depend. 2003; 70(2): 117-125.
5. Miller NS, Greenfield A: Patient characteristics and risk factors for development of dependence on hydrocodone and oxycodone. Am J Ther. 2004; 11(1): 26-32.
6. Levy S, Harris SK, Sherritt L, et al.: Drug testing of adolescents in ambulatory medicine: Physician practices and knowledge. Arch Pediatr Adolesc Med. 2006; 160(2): 146-150.
7. Heit HA, Gourlay DL: Urine drug testing in pain medicine. J Pain Symptom Manage. 2004; 27(3): 260-267.
8. Lee HK, Lewis LD, Tsongalis GJ, et al.: Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism. Clin Chim Acta. 2006; 367(1-2): 196-200.
9. Goldstein A, Brown BW: Urine testing in methadone maintenance treatment: Applications and limitations. J Subst Abuse Treat. 2003; 25(2): 61-63.
10. Durback LF, Scharman EJ, Brown BS: Emergency physicians' perceptions of drug screens at their own hospitals. Vet Hum Toxicol. 1998; 40(4): 234-237.
11. Downing SM: The effects of violating standard item writing principles on tests and students: The consequences of using flawed test items on achievement examinations in medical education. Adv Health Sci Educ Theory Pract. 2005; 10(2): 133-143.
12. Upshur CC, Luckmann RS, Savageau JA: Primary care provider concerns about management of chronic pain in community clinic populations. J Gen Intern Med. 2006; 21(6): 652-655.
13. Ponte CD, Johnson-Tribino J: Attitudes and knowledge about pain: An assessment of West Virginia family physicians. Fam Med. 2005; 37(7): 477-480.
14. Gourlay D, Heit HA, Caplan YH: Urine Drug Testing in Primary Care: Dispelling the Myths and Designing Strategies. San Francisco: California Academy of Family Physicians, PharmaCom Group, 2002.
15. Swotinsky R, Smith D: The Medical Review Officer's Manual, 3rd ed. Beverly Farms, MA: OEM Press, 2006.